Leo Albert

1.4k total citations
17 papers, 1.1k citations indexed

About

Leo Albert is a scholar working on Immunology, Genetics and Oncology. According to data from OpenAlex, Leo Albert has authored 17 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 7 papers in Genetics and 5 papers in Oncology. Recurrent topics in Leo Albert's work include Immune Cell Function and Interaction (4 papers), Inflammatory Bowel Disease (4 papers) and T-cell and B-cell Immunology (4 papers). Leo Albert is often cited by papers focused on Immune Cell Function and Interaction (4 papers), Inflammatory Bowel Disease (4 papers) and T-cell and B-cell Immunology (4 papers). Leo Albert collaborates with scholars based in United States, Canada and China. Leo Albert's co-authors include James C. Keith, Heather A. Harris, Douglas C. Harnish, Richard C. Winneker, A Eckert, Chris P. Miller, Yuan Zhu, Yogendra P. Kharode, Andrew J. Dorner and Donald E. Frail and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Gastroenterology and Endocrinology.

In The Last Decade

Leo Albert

17 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leo Albert United States 11 472 377 265 193 173 17 1.1k
Saara Aittomäki Finland 15 357 0.8× 126 0.3× 352 1.3× 435 2.3× 63 0.4× 25 966
Simone M. Blattner Germany 15 287 0.6× 182 0.5× 153 0.6× 513 2.7× 72 0.4× 19 1.5k
Lucia Picariello Italy 17 145 0.3× 496 1.3× 217 0.8× 277 1.4× 82 0.5× 24 976
Seiichiro Tarui Japan 17 375 0.8× 225 0.6× 118 0.4× 523 2.7× 96 0.6× 40 1.3k
Michi Tanaka Japan 14 147 0.3× 112 0.3× 107 0.4× 232 1.2× 333 1.9× 25 959
A. J. Tigges Netherlands 12 365 0.8× 141 0.4× 198 0.7× 195 1.0× 32 0.2× 16 900
Isabella Tosi United Kingdom 15 986 2.1× 132 0.4× 134 0.5× 327 1.7× 148 0.9× 29 1.8k
Yoshikazu Kawanishi Japan 7 467 1.0× 90 0.2× 459 1.7× 345 1.8× 58 0.3× 16 1.1k
Ann Biehl United States 5 359 0.8× 77 0.2× 283 1.1× 231 1.2× 261 1.5× 8 970
Federica Villanova United Kingdom 12 1.1k 2.4× 114 0.3× 207 0.8× 295 1.5× 214 1.2× 14 1.6k

Countries citing papers authored by Leo Albert

Since Specialization
Citations

This map shows the geographic impact of Leo Albert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leo Albert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leo Albert more than expected).

Fields of papers citing papers by Leo Albert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leo Albert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leo Albert. The network helps show where Leo Albert may publish in the future.

Co-authorship network of co-authors of Leo Albert

This figure shows the co-authorship network connecting the top 25 collaborators of Leo Albert. A scholar is included among the top collaborators of Leo Albert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leo Albert. Leo Albert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Clerin, Valérie, Heather H. Shih, Nanhua Deng, et al.. (2008). Expression of the cysteine protease legumain in vascular lesions and functional implications in atherogenesis. Atherosclerosis. 201(1). 53–66. 45 indexed citations
2.
Young, Deborah, Martin Hegen, Matthew J. Whitters, et al.. (2007). Blockade of the interleukin‐21/interleukin‐21 receptor pathway ameliorates disease in animal models of rheumatoid arthritis. Arthritis & Rheumatism. 56(4). 1152–1163. 238 indexed citations
3.
Keith, James C., Leo Albert, Max Follettie, et al.. (2005). The utility of pathway selective estrogen receptor ligands that inhibit nuclear factor-κB transcriptional activity in models of rheumatoid arthritis. Arthritis Research & Therapy. 7(3). R427–38. 48 indexed citations
4.
Keith, James C., Irma M. Sáinz, Irma Isordia‐Salas, et al.. (2005). A monoclonal antibody against kininogen reduces inflammation in the HLA-B27 transgenic rat. Arthritis Research & Therapy. 7(4). R769–76. 15 indexed citations
5.
Chadwick, Christopher C., Susan Chippari, Edward Matelan, et al.. (2005). Identification of pathway-selective estrogen receptor ligands that inhibit NF-κB transcriptional activity. Proceedings of the National Academy of Sciences. 102(7). 2543–2548. 112 indexed citations
6.
Harnish, Douglas C., Leo Albert, A Eckert, et al.. (2004). Beneficial effects of estrogen treatment in the HLA-B27 transgenic rat model of inflammatory bowel disease. American Journal of Physiology-Gastrointestinal and Liver Physiology. 286(1). G118–G125. 96 indexed citations
7.
Harris, Heather A., Leo Albert, Michael S. Malamas, et al.. (2003). Evaluation of an Estrogen Receptor-β Agonist in Animal Models of Human Disease. Endocrinology. 144(10). 4241–4249. 267 indexed citations
8.
Albert, Leo, et al.. (2002). Pharmacogenomic analysis of rhIL-11 treatment in the HLA-B27 rat model of inflammatory bowel disease. The Pharmacogenomics Journal. 2(6). 383–399. 11 indexed citations
9.
Albert, Leo, et al.. (2000). In Vivo Absorption Properties of Orally Administered Recombinant Human Interleukin-11. Pharmaceutical Research. 17(4). 482–485. 5 indexed citations
10.
Peterson, Ron, Lili Wang, Leo Albert, & Andrew J. Dorner. (2000). SUBCUTANEOUS OR ORAL ADMINISTRATION OF rhIL-11 MODULATES THE CONTACT HYPERSENSITIVITY RESPONSE. Cytokine. 12(12). 1769–1777. 4 indexed citations
11.
Albert, Leo, et al.. (2000). Serial renal biopsy in systemic lupus erythematosus.. PubMed. 27(12). 2822–6. 55 indexed citations
12.
Keith, James C., Leo Albert, Leo Tseng, et al.. (2000). Oral delivery of recombinant human interleukin-11 decreases clinical signs and histologic lesions in animal models of inflammatory bowel disease. Gastroenterology. 118(4). A701–A701. 1 indexed citations
13.
Peterson, Ron, et al.. (1998). Molecular mechanism of interleukin-11 in the HLA-B27 rat model of inflammatory bowel disease. Gastroenterology. 114. A1060–A1060. 6 indexed citations
15.
Peterson, Ron, Lili Wang, Leo Albert, James C. Keith, & Andrew J. Dorner. (1998). Molecular effects of recombinant human interleukin-11 in the HLA-B27 rat model of inflammatory bowel disease.. PubMed. 78(12). 1503–12. 81 indexed citations
16.
Albert, Leo, et al.. (1996). Cryocrystalglobulinemia mimicking rheumatoid arthritis and vasculitis.. PubMed. 23(7). 1272–7. 10 indexed citations
17.
Albert, Leo, et al.. (1994). IL-11, a pleiotropic cytokine: exciting new effects of IL-11 on gastrointestinal mucosal biology.. PubMed. 12 Suppl 1. 79–89; discussion 89. 106 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026